COMPARISON OF METOCLOPRAMIDE AND METOCLOPRAMIDE PLUS DEXAMETHASONE FOR COMPLETE PROTECTION FROM CISPLATINUM-INDUCED EMESIS

被引:40
作者
GRUNBERG, SM
AKERLEY, WL
KRAILO, MD
JOHNSON, KB
BAKER, CR
CARIFFE, PA
机构
[1] UNIV SO CALIF,LOS ANGELES CTY MED CTR,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA 90033
关键词
D O I
10.3109/07357908609017518
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:379 / 385
页数:7
相关论文
共 22 条
[1]  
AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11
[2]   DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].
AAPRO, MS ;
PLEZIA, PM ;
ALBERTS, DS ;
GRAHAM, V ;
JONES, SE ;
SURWIT, EA ;
MOON, TE .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471
[3]   DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE - EFFICACY IN CONTROLLING CISPLATIN INDUCED NAUSEA AND VOMITING [J].
ALLAN, SG ;
CORNBLEET, MA ;
WARRINGTON, PS ;
GOLLAND, IM ;
LEONARD, RCF ;
SMYTH, JF .
BRITISH MEDICAL JOURNAL, 1984, 289 (6449) :878-879
[4]  
BISHOP YMM, 1975, DISCRETE MULTIVARIAT, P357
[5]   ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE IN INDUCTION THERAPY IN ACUTE NONLYMPHOCYTIC LEUKEMIA [J].
CASSILETH, PA ;
LUSK, EJ ;
TORRI, S ;
GERSON, SL .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) :701-702
[6]  
DEVITA VT, 1977, HARRISONS PRINCIPLES, P1745
[7]  
DONOVITZ GS, 1984, GYNECOL ONCOL, V18, P320, DOI 10.1016/0090-8258(84)90043-X
[8]   IMPORTANCE OF BETA, TYPE-II ERROR AND SAMPLE-SIZE IN DESIGN AND INTERPRETATION OF RANDOMIZED CONTROL TRIAL - SURVEY OF 71 NEGATIVE TRIALS [J].
FREIMAN, JA ;
CHALMERS, TC ;
SMITH, H ;
KUEBLER, RR .
NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (13) :690-694
[9]   ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].
GRALLA, RJ ;
ITRI, LM ;
PISKO, SE ;
SQUILLANTE, AE ;
KELSEN, DP ;
BRAUN, DW ;
BORDIN, LA ;
BRAUN, TJ ;
YOUNG, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909
[10]   COMPARISON OF THE ANTIEMETIC EFFECT OF HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE AND HIGH-DOSE INTRAVENOUS HALOPERIDOL IN A RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY [J].
GRUNBERG, SM ;
GALA, KV ;
LAMPENFELD, M ;
JAMIN, D ;
JOHNSON, K ;
CARIFFE, P ;
STRYCH, D ;
KRAILO, M .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) :782-787